Analyzing Concurrent Warfarin and Aspirin Intake for Stroke Patients and Related Factors Based on National Health Insurance Database
碩士 === 長庚大學 === 醫務管理學研究所 === 97 === Stroke is the second leading cause of death in Taiwan for many years, and also resulted in long-term disability. Warfarin is an effective therapy for both the treatment and prevention of Stroke. However, the use of warfarin should be under close surveillance, or i...
Main Authors: | Hsiao Han Duann, 段曉涵 |
---|---|
Other Authors: | H. I Wang |
Format: | Others |
Published: |
2009
|
Online Access: | http://ndltd.ncl.edu.tw/handle/32455131020249452485 |
Similar Items
-
Warfarin- and aspirin-associated fetal intracranial haemorrhage
by: Laila Matar, et al.
Published: (2016-01-01) -
The Prevalence and Risks of Inappropriate Combination of Aspirin and Warfarin in Clinical Practice: Results From WARFARIN-TR Study
by: Salih Kılıç, et al.
Published: (2019-01-01) -
Effect of warfarin versus aspirin on blood viscosity in cardioembolic stroke with atrial fibrillation: a prospective clinical trial
by: Chan-Hyuk Lee, et al.
Published: (2019-05-01) -
A Study Of Applying Data Mining Technology To The National Health Insurance Research Database To Analyze The Death Of Stroke Patients
by: Li-Wen Chang, et al.
Published: (2012) -
A net clinical benefit analysis of warfarin and aspirin on stroke in patients with atrial fibrillation: a nested case–control study
by: Azoulay Laurent, et al.
Published: (2012-06-01)